MAPT and Alzheimer disease: However, when the dataset from the ACA was compared with our Aβ+/tau– versus control dataset from the smaller cohort, a strong correlation was observed (r = 0.893) (Fig. 3E), further supporting the consistency of the proteomic changes identified in this AD subgroup.